Thursday, 13 December, 2018

Blood pressure medicine recalled over risky mix-up

DNY59—Getty Images  iStock DNY59—Getty Images iStock
Melissa Porter | 31 August, 2018, 22:58

Accord - the company that distributes the drug - is recalling this individual lot from the market due to the "potential mix-up of labeling".

Accord Healthcare has recalled one lot of 12.5-milligram hydrochlorothiazide tablets because the 100-count bottle was discovered to contain 100 spironolactone tablets.

Both medications are used to treat high blood pressure, but according to CBS News, the FDA warns that taking spironolactone instead of hydrochlorothiazide could pose the risk of hyperkalemia for some.

The medication found in the bottle was created to reduce a hormone that affects blood pressure.

All of these effects are the result of elevated potassium levels.

To date, the drugmaker has not received reports of adverse events in connection with the labeling mix-up.

Hydrochlorothiazide tablets are used in the treatment of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.

This could result in adverse events, including life-threatening situations in some people.

No injuries have been reported, the FDA said.

Spironolactone can be used to treat heart problems, high blood pressure, low potassium levels and fluid retention for some maladies, according to The recall does not affect hydrochlorothiazide sold by other drug companies.

The hydrochlorothiazide tablets are light orange or peach in color, are round, and have an "H" on one side and a "1" on the other. The affected drugs in that recall may have been contaminated with N-nitrosodimethylamine or NDMA, which the U.S. Environmental Protection Agency considers a possible carcinogen.